Iovance Biotherapeutics, Inc. Announces Pricing Of Its Public Offering Of $150 Million Of Common Stock

Iovance Biotherapeutics, Inc. today announced the pricing of an underwritten public offering of 13,043,479 shares of its common stock at a public offering price of $11.50 per share.